查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1810837

2025年全球可生物分解止血劑市場報告

Biodegradable Hemostat Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年可生物分解止血鉗市場將快速成長，到2029年將達到14.8億美元，年複合成長率（CAGR）為10.9%。預測期內的成長主要源於以下因素：全球外科手術數量的增加、對可生物分解醫療產品的偏好日益成長、創傷和事故案例的上升、人口老齡化以及對微創手術的需求不斷成長。預計在此期間的主要趨勢包括傷口護理技術的進步、可生物分解材料的創新、對可吸收植入需求的不斷成長、產品包裝和交付方式的改進以及混合止血鉗的開發。

預計手術數量的增加將推動可生物分解止血鉗市場的擴張。手術是指由醫療專業人員使用專門的器械因健康原因治療、修復或切除身體部位的醫療程序。手術數量的增加主要是由於慢性病的發生率上升，這些疾病通常需要手術干預來控制病情並改善患者預後。可生物分解止血鉗在使用後會在體內自然分解，無需取出，並降低術後併發症的風險，從而為手術帶來益處。例如，2023 年 3 月，英國專業組織英國美容整形外科醫生協會 (BAAPS) 報告稱，2022 年共進行了 31,057 例整容手術，比前一年增加了 102%。其中女性佔 93%，與 2021 年相比成長了 101%。因此，手術數量的增加正在推動可生物分解止血鉗市場的發展。

創傷和事故發生頻率的不斷上升預計將進一步推動可生物分解止血鉗市場的成長。創傷和事故是指因跌倒、撞擊和碰撞等外力而導致身體損傷的意外事件，通常需要緊急醫療救治。此類創傷的增加很大程度上是由於交通事故的增加，而交通事故的增加是由車輛使用量的增加和快速的都市化造成的，使更多人面臨危險的駕駛條件。在這種情況下，對可生物分解止血鉗的需求正在成長，因為它們能夠快速控制嚴重出血並在體內安全分解，這使得它們在急救和外科手術環境中特別有用。例如，根據加拿大政府機構加拿大運輸部2024年5月的公告，2022年機車事故死亡人數為1,931人，比2021年的1,821人增加了6.0%。重傷人數也增加了8.1%，從2021年的8,185人增加到2022年的8,851人。因此，創傷和事故的增加正在推動可生物分解止血鉗市場向前發展。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球可生物分解止血劑：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球可生物分解止血劑市場：成長率分析
  • 全球可生物分解止血劑市場表現：規模與成長，2019-2024
  • 全球可生物分解止血劑市場預測：規模與成長，2024-2029年，2034年
  • 全球可生物分解止血劑：總目標市場（TAM）

第6章 市場細分

  • 全球可生物分解止血劑市場（按產品類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 天然聚合物基止血材料
  • 合成聚合物基止血材料
  • 複合止血鉗
  • 纖維素基止血材料
  • 明膠基止血材料
  • 全球可生物分解止血劑市場：按配方、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 粉狀止血劑
  • 顆粒止血劑
  • 液體止血劑
  • 泡沫止血鉗
  • 薄膜或片狀止血劑
  • 全球可生物分解止血劑市場：應用、效能及預測，2019-2024年、2024-2029年、2034年
  • 外科手術
  • 創傷治療
  • 牙科手術
  • 腹腔鏡手術
  • 其他用途
  • 全球可生物分解止血劑市場（依通路、績效及預測）2019-2024、2024-2029、2034
  • 直銷
  • 經銷商
  • 電商平台
  • 醫藥零售商
  • 醫療保健供應公司
  • 全球可生物分解止血劑市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 診所
  • 研究辦公室
  • 其他最終用戶
  • 全球可生物分解止血劑市場：天然聚合物基止血劑細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 膠原蛋白蛋白基
  • 幾丁聚醣基
  • 海藻酸鹽基
  • 基於纖維蛋白
  • 聚葡萄糖基
  • 全球可生物分解止血劑市場：依合成聚合物基止血劑類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 聚乙二醇（PEG）基
  • 聚氨酯基底
  • 聚乳酸（PLA）基
  • Polyglycolic（PGA）基
  • 聚己內酯（PCL）基
  • 全球可生物分解止血劑市場：按複合止血劑類型細分、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 天然和合成聚合物混合物
  • 聚合物-纖維素複合材料
  • 聚合物-明膠複合材料
  • 多層複合材料
  • 奈米複合止血劑
  • 全球可生物分解止血劑市場：纖維素基止血劑細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 氧化再生纖維素（ORC）
  • 微晶纖維素（MCC）
  • 羧甲基纖維素（CMC）
  • 奈米纖維素基
  • 羥丙基纖維素（HPC）
  • 全球可生物分解止血劑市場：明膠基止血劑細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 豬肉明膠底料
  • 牛明膠底料
  • 魚膠基
  • 交聯明膠
  • 改質明膠製劑

第7章 區域和國家分析

  • 全球可生物分解止血劑市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球可生物分解止血劑市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 可生物分解止血材料市場：競爭格局
  • 可生物分解止血劑市場：公司簡介
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Medline Industries LP Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Co. Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Baxter International Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Samyang Holdings Corp.
  • Molnlycke Health Care AB
  • GELITA Medical GmbH
  • B. Braun Melsungen AG
  • Tricol Biomedical Inc.
  • Medtrade Products Limited
  • CryoLife Inc.
  • Hemostasis LLC
  • Cura Medical
  • RevMedx Inc.
  • Speed Care Mineral GmbH
  • Regenity
  • CR Bard Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年可生物分解止血劑市場：提供新機會的國家
  • 2029年可生物分解止血劑市場：細分市場帶來新機會
  • 2029年可生物分解止血劑市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r36935

A biodegradable hemostat is a medical device designed to assist in blood clotting and control bleeding by triggering or speeding up the body's natural coagulation process. It is made to be safely absorbed and broken down by the body over time, eliminating the need for surgical removal. These hemostats are developed with biocompatibility to reduce the risk of adverse reactions while promoting wound healing.

The main types of biodegradable hemostats include natural polymer-based, synthetic polymer-based, composite, cellulose-based, and gelatin-based hemostats. Natural polymer-based hemostats are derived from naturally sourced polymers that aid in stopping bleeding by supporting blood clot formation during medical procedures. They come in various forms such as powders, granules, liquids, foams, and films or sheets, and are used in surgeries, trauma care, dental procedures, laparoscopic surgeries, and more. These products are distributed through direct sales, distributors, e-commerce platforms, pharmaceutical retailers, and healthcare supply companies, serving end users like hospitals, ambulatory surgical centers, clinics, research labs, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The biodegradable hemostat market research report is one of a series of new reports from The Business Research Company that provides biodegradable hemostat market statistics, including biodegradable hemostat industry global market size, regional shares, competitors with a biodegradable hemostat market share, detailed biodegradable hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the biodegradable hemostat industry. This biodegradable hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biodegradable hemostat market size has grown rapidly in recent years. It will grow from $0.88 billion in 2024 to $0.97 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth during the historical period can be attributed to increased awareness of post-surgical complications, supportive government regulations, a rise in chronic diseases such as cancer and cardiovascular disorders, expansion in the number of hospitals and surgical centers, and heightened investment in healthcare infrastructure.

The biodegradable hemostat market size is expected to see rapid growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth anticipated in the forecast period can be attributed to the increasing number of surgical procedures globally, a growing preference for biodegradable medical products, rising cases of trauma and accidents, an aging population, and higher demand for minimally invasive surgeries. Key trends expected during this period include advancements in wound care technology, innovations in biodegradable materials, increased demand for absorbable implants, enhanced product packaging and delivery formats, and the development of hybrid hemostats.

The growing number of surgical procedures is anticipated to drive the expansion of the biodegradable hemostat market. Surgical procedures involve medical operations conducted by healthcare professionals using specialized tools to treat, repair, or remove body parts for health reasons. This increase in surgeries is primarily due to the rising prevalence of chronic diseases, which often require surgical intervention to manage conditions and improve patient outcomes. Biodegradable hemostats provide benefits during surgery by breaking down naturally within the body after use, eliminating the need for removal and reducing the risk of post-operative complications. For example, in March 2023, the British Association of Aesthetic Plastic Surgeons (BAAPS), a UK-based professional body, reported that 31,057 cosmetic procedures were performed in 2022, representing a 102% increase from the previous year. Women accounted for 93% of these procedures, showing a 101% rise compared to 2021. Hence, the rise in surgical procedures is boosting the biodegradable hemostat market.

The increasing frequency of trauma and accidents is expected to further fuel growth in the biodegradable hemostat market. Trauma and accidents are unexpected incidents causing physical injuries due to external forces like falls, impacts, or collisions, often requiring urgent medical care. This rise in trauma cases is largely driven by an increase in road traffic accidents, which result from higher vehicle usage and rapid urbanization, exposing more individuals to hazardous driving conditions. Biodegradable hemostats are in greater demand in such cases as they quickly control severe bleeding and safely degrade within the body, making them especially valuable in emergency and surgical settings. For instance, in May 2024, Transport Canada, a Canadian government agency, reported that motor vehicle fatalities increased to 1,931 in 2022, a 6.0% rise from 1,821 deaths in 2021. Serious injuries also grew by 8.1%, climbing from 8,185 in 2021 to 8,851 in 2022. Therefore, the rise in trauma and accidents is propelling the biodegradable hemostat market forward.

Key players in the biodegradable hemostat market are concentrating on developing innovative solutions such as plant-based cellulose matrices to rapidly control bleeding and reduce blood loss. Plant-based cellulose matrices are biodegradable materials derived from plant fibers that provide a natural support structure and are safely absorbed by the body, making them suitable for medical use. In April 2024, LifeScience PLUS, a US-based medical device company, introduced DonorSeal, a distinctive hemostatic dressing made entirely from plant-sourced cellulose. DonorSeal forms a gel upon contact with blood, effectively stopping bleeding while being fully biodegradable, absorbable, non-toxic, and pH neutral, making it safe for patients on blood thinners. It also creates a moist, soothing environment that promotes natural tissue healing. The dressing can be removed easily without reopening wounds or sticking, enhancing comfort and speeding recovery at donor sites.

Major players in the biodegradable hemostat market are Johnson & Johnson Services Inc., Medtronic Plc, Medline Industries LP, Becton, Dickinson and Co., Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Samyang Holdings Corp., Molnlycke Health Care AB, GELITA Medical GmbH, B. Braun Melsungen AG, Tricol Biomedical Inc., Medtrade Products Limited, CryoLife Inc., Hemostasis LLC, Cura Medical, RevMedx Inc., Speed Care Mineral GmbH, Regenity, and C. R. Bard Inc.

North America was the largest region in the biodegradable hemostat market in 2024. The regions covered in biodegradable hemostat report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biodegradable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biodegradable hemostat market consists of sales of polysaccharide hemostatic powders, flowable hemostatic agents, plant-based absorbable hemostats, and hydrogel-based hemostatic patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biodegradable Hemostat Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biodegradable hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biodegradable hemostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biodegradable hemostat market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Natural Polymer-Based Hemostats; Synthetic Polymer-Based Hemostats; Composite Hemostats; Cellulose-Based Hemostats; Gelatin-Based Hemostats
  • 2) By Formulation: Powdered Hemostats; Granular Hemostats; Liquid Hemostats; Foam Hemostats; Film Or Sheet Hemostats
  • 3) By Application: Surgical Procedures; Trauma Procedures; Dental Procedures; Laparoscopic Procedures; Other Applications
  • 4) By Distribution Channel: Direct Sales; Distributors; E-Commerce Platforms; Pharmaceutical Retailers; Healthcare Supply Companies
  • 5) By End-User: Hospitals; Ambulatory Surgical Centers; Clinics; Research Laboratories; Other End Users
  • Subsegments:
  • 1) By Natural Polymer-Based Hemostats: Collagen-Based; Chitosan-Based; Alginate-Based; Fibrin-Based; Dextran-Based
  • 2) By Synthetic Polymer-Based Hemostats: Polyethylene Glycol (PEG)-Based; Polyurethane-Based; Polylactic Acid (PLA)-Based; Polyglycolic Acid (PGA)-Based; Polycaprolactone (PCL)-Based
  • 3) By Composite Hemostats: Natural-Synthetic Polymer Blends; Polymer-Cellulose Composites; Polymer-Gelatin Composites; Multi-Layer Composites; Nano-Composite Hemostats
  • 4) By Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC); Microcrystalline Cellulose (MCC); Carboxymethyl Cellulose (CMC); Nanocellulose-Based; Hydroxypropyl Cellulose (HPC)
  • 5) By Gelatin-Based Hemostats: Porcine Gelatin-Based; Bovine Gelatin-Based; Fish Gelatin-Based; Cross-Linked Gelatin; Modified Gelatin Formulations
  • Companies Mentioned: Johnson & Johnson Services Inc.; Medtronic Plc; Medline Industries LP; Becton, Dickinson and Co.; Stryker Corporation; Baxter International Inc.; Meril Life Sciences Pvt. Ltd.; Samyang Holdings Corp.; Molnlycke Health Care AB; GELITA Medical GmbH; B. Braun Melsungen AG; Tricol Biomedical Inc.; Medtrade Products Limited; CryoLife Inc.; Hemostasis LLC; Cura Medical; RevMedx Inc.; Speed Care Mineral GmbH; Regenity; C. R. Bard Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biodegradable Hemostat Market Characteristics

3. Biodegradable Hemostat Market Trends And Strategies

4. Biodegradable Hemostat Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biodegradable Hemostat Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Biodegradable Hemostat PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Biodegradable Hemostat Market Growth Rate Analysis
  • 5.4. Global Biodegradable Hemostat Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Biodegradable Hemostat Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Biodegradable Hemostat Total Addressable Market (TAM)

6. Biodegradable Hemostat Market Segmentation

  • 6.1. Global Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Natural Polymer-Based Hemostats
  • Synthetic Polymer-Based Hemostats
  • Composite Hemostats
  • Cellulose-Based Hemostats
  • Gelatin-Based Hemostats
  • 6.2. Global Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Powdered Hemostats
  • Granular Hemostats
  • Liquid Hemostats
  • Foam Hemostats
  • Film Or Sheet Hemostats
  • 6.3. Global Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical Procedures
  • Trauma Procedures
  • Dental Procedures
  • Laparoscopic Procedures
  • Other Applications
  • 6.4. Global Biodegradable Hemostat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Sales
  • Distributors
  • E-Commerce Platforms
  • Pharmaceutical Retailers
  • Healthcare Supply Companies
  • 6.5. Global Biodegradable Hemostat Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Research Laboratories
  • Other End Users
  • 6.6. Global Biodegradable Hemostat Market, Sub-Segmentation Of Natural Polymer-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Collagen-Based
  • Chitosan-Based
  • Alginate-Based
  • Fibrin-Based
  • Dextran-Based
  • 6.7. Global Biodegradable Hemostat Market, Sub-Segmentation Of Synthetic Polymer-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polyethylene Glycol (PEG)-Based
  • Polyurethane-Based
  • Polylactic Acid (PLA)-Based
  • Polyglycolic Acid (PGA)-Based
  • Polycaprolactone (PCL)-Based
  • 6.8. Global Biodegradable Hemostat Market, Sub-Segmentation Of Composite Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Natural-Synthetic Polymer Blends
  • Polymer-Cellulose Composites
  • Polymer-Gelatin Composites
  • Multi-Layer Composites
  • Nano-Composite Hemostats
  • 6.9. Global Biodegradable Hemostat Market, Sub-Segmentation Of Cellulose-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oxidized Regenerated Cellulose (ORC)
  • Microcrystalline Cellulose (MCC)
  • Carboxymethyl Cellulose (CMC)
  • Nanocellulose-Based
  • Hydroxypropyl Cellulose (HPC)
  • 6.10. Global Biodegradable Hemostat Market, Sub-Segmentation Of Gelatin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Porcine Gelatin-Based
  • Bovine Gelatin-Based
  • Fish Gelatin-Based
  • Cross-Linked Gelatin
  • Modified Gelatin Formulations

7. Biodegradable Hemostat Market Regional And Country Analysis

  • 7.1. Global Biodegradable Hemostat Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Biodegradable Hemostat Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biodegradable Hemostat Market

  • 8.1. Asia-Pacific Biodegradable Hemostat Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biodegradable Hemostat Market

  • 9.1. China Biodegradable Hemostat Market Overview
  • 9.2. China Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biodegradable Hemostat Market

  • 10.1. India Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biodegradable Hemostat Market

  • 11.1. Japan Biodegradable Hemostat Market Overview
  • 11.2. Japan Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biodegradable Hemostat Market

  • 12.1. Australia Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biodegradable Hemostat Market

  • 13.1. Indonesia Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biodegradable Hemostat Market

  • 14.1. South Korea Biodegradable Hemostat Market Overview
  • 14.2. South Korea Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biodegradable Hemostat Market

  • 15.1. Western Europe Biodegradable Hemostat Market Overview
  • 15.2. Western Europe Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biodegradable Hemostat Market

  • 16.1. UK Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biodegradable Hemostat Market

  • 17.1. Germany Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biodegradable Hemostat Market

  • 18.1. France Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biodegradable Hemostat Market

  • 19.1. Italy Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biodegradable Hemostat Market

  • 20.1. Spain Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biodegradable Hemostat Market

  • 21.1. Eastern Europe Biodegradable Hemostat Market Overview
  • 21.2. Eastern Europe Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biodegradable Hemostat Market

  • 22.1. Russia Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biodegradable Hemostat Market

  • 23.1. North America Biodegradable Hemostat Market Overview
  • 23.2. North America Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biodegradable Hemostat Market

  • 24.1. USA Biodegradable Hemostat Market Overview
  • 24.2. USA Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biodegradable Hemostat Market

  • 25.1. Canada Biodegradable Hemostat Market Overview
  • 25.2. Canada Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biodegradable Hemostat Market

  • 26.1. South America Biodegradable Hemostat Market Overview
  • 26.2. South America Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biodegradable Hemostat Market

  • 27.1. Brazil Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biodegradable Hemostat Market

  • 28.1. Middle East Biodegradable Hemostat Market Overview
  • 28.2. Middle East Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biodegradable Hemostat Market

  • 29.1. Africa Biodegradable Hemostat Market Overview
  • 29.2. Africa Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biodegradable Hemostat Market Competitive Landscape And Company Profiles

  • 30.1. Biodegradable Hemostat Market Competitive Landscape
  • 30.2. Biodegradable Hemostat Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medline Industries LP Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickinson and Co. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Biodegradable Hemostat Market Other Major And Innovative Companies

  • 31.1. Baxter International Inc.
  • 31.2. Meril Life Sciences Pvt. Ltd.
  • 31.3. Samyang Holdings Corp.
  • 31.4. Molnlycke Health Care AB
  • 31.5. GELITA Medical GmbH
  • 31.6. B. Braun Melsungen AG
  • 31.7. Tricol Biomedical Inc.
  • 31.8. Medtrade Products Limited
  • 31.9. CryoLife Inc.
  • 31.10. Hemostasis LLC
  • 31.11. Cura Medical
  • 31.12. RevMedx Inc.
  • 31.13. Speed Care Mineral GmbH
  • 31.14. Regenity
  • 31.15. C. R. Bard Inc.

32. Global Biodegradable Hemostat Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biodegradable Hemostat Market

34. Recent Developments In The Biodegradable Hemostat Market

35. Biodegradable Hemostat Market High Potential Countries, Segments and Strategies

  • 35.1 Biodegradable Hemostat Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Biodegradable Hemostat Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Biodegradable Hemostat Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer